BioNTech SE (BNTX)

NASDAQ: BNTX · Real-Time Price · USD

102.58

-1.57 (-1.51%)

At close: May 01, 2025, 3:59 PM

104.93

2.29%

Pre-market: May 02, 2025, 07:25 AM EDT

BioNTech SE Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	2.75B	3.82B	17.31B	18.98B	482.32M	108.59M	127.58M	61.6M
Cost of Revenue	541.3M	599.8M	4.53B	3.86B	704.36M	243.83M	156.73M	94.81M
Gross Profit	2.21B	3.22B	12.78B	15.12B	-222.04M	-135.24M	-29.16M	-33.22M
Operating Income	-1.31B	690.4M	12.64B	15.28B	-82.42M	-181.52M	-53.85M	-61.28M
Interest Income	437.6M	350.27M	330.3M	1.5M	1.56M	1.78M	2M	2.13M
Pretax Income	-677.7M	1.19B	12.95B	15.05B	-145.8M	-179.44M	-47.66M	-85.91M
Net Income	-665.3M	930.3M	9.43B	10.29B	15.2M	-179.17M	-48.02M	-85.65M
Selling & General & Admin	599M	557.7M	544.2M	328.9M	108.56M	43.41M	27.09M	29.49M
Research & Development	2.25B	1.78B	1.46B	952.85M	645.03M	226.47M	143.04M	85.5M
Other Expenses	670.9M	188M	-408.3M	-128.8M	-893.21M	-223.6M	-145.43M	-86.93M
Operating Expenses	3.52B	2.53B	135.9M	200.1M	-139.62M	46.28M	24.7M	28.06M
Interest Expense	12.6M	569.94K	18.9M	5.4M	64.95M	1.72M	1.72M	676K
Selling & Marketing Expenses	67.9M	62.7M	59.5M	50.4M	14.51M	2.72M	3.04M	6.6M
Cost & Expenses	4.07B	3.13B	4.67B	4.06B	564.74M	290.11M	181.43M	122.88M
Income Tax Expense	-12.4M	255.8M	3.52B	4.75B	-161M	-268K	600K	45K
Shares Outstanding (Basic)	240.18M	240.6M	243.3M	244M	235.44M	211.5M	226.86M	226.86M
Shares Outstanding (Diluted)	240.18M	242.7M	249.8M	259.7M	248.53M	211.5M	226.86M	226.86M
EPS (Basic)	-2.77	3.87	38.08	43.87	0.06	-0.85	-0.21	-0.38
EPS (Diluted)	-2.77	3.83	37.09	41.21	0.06	-0.85	-0.21	-0.38
EBITDA	-367.1M	1.09B	12.86B	15.73B	-97.89M	-143.41M	-24.64M	-70.13M
EBIT	-665.1M	1.19B	12.74B	15.65B	-133.99M	-177.7M	-47.33M	-79.98M
Depreciation & Amortization	298M	183.4M	121.08M	78.2M	36.1M	33.8M	22.69M	9.85M